Article thumbnail
Location of Repository

Overexpression of tissue inhibitors of metalloproteinase 2 up-regulates NF-κB activity in melanoma cells

By Jun Sun and William G Stetler-Stevenson
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1997). A: Enhanced degradation of IkappaB alpha contributes to endogenous activation of NFkappaB in Hs294T melanoma cells. Cancer research
  2. (2005). A: Role of nuclear factor-kappa B in melanoma. Cancer metastasis reviews
  3. (1998). Albini A: TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. International journal of cancer
  4. (1996). CL: TIMP-2 growth-stimulatory activity: a concentration- and cell type-specific response in the presence of insulin. Experimental cell research
  5. (2004). GA: Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke a journal of cerebral circulation
  6. (2000). IJ: Level of interleukin8 expression by metastatic human melanoma cells directly correlates with constitutive NF-kappaB activity. Cytokines, cellular & molecular therapy
  7. (2005). JL: Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells. American journal of physiology
  8. (2008). Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells.
  9. (2004). M: IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell
  10. (2004). NF-kappaB: tumor promoter or suppressor? Trends in cell biology
  11. (2005). Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer
  12. (2006). Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells. Mol Cancer Res
  13. (2007). Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response. Experimental cell research
  14. (2004). Signaling to NF-kappaB. Genes Dev
  15. (1995). Stetler-Stevenson WG: Gelatinase A activity directly modulates melanoma cell adhesion and spreading. The EMBO journal
  16. (1995). Stetler-Stevenson WG: Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. The Journal of biological chemistry
  17. (1996). T: Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). FEBS letters
  18. (2004). The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer letters
  19. (2004). The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol
  20. (2004). Tissue inhibitor of metalloproteinases-2 growth-stimulatory activity is mediated by nuclear factor-kappa B in A549 lung epithelial cells. The international journal of biochemistry & cell biology
  21. (2008). Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Science signaling
  22. (1999). Tohidian NB: Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress. Clin Cancer Res
  23. (1999). Toriumi W: IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. The Journal of biological chemistry

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.